Adjuvant Radiotherapy and/or Chemotherapy for Endometrial Cancer, Status as at 2019: Opinion of the Uterus Commission of the Gynecological Oncology Working Group (AGO).
Adjuvant Radiotherapy and/or Chemotherapy for Endometrial Cancer, Status as at 2019: Opinion of the Uterus Commission of the Gynecological Oncology Working Group (AGO).
Geburtshilfe Frauenheilkd. 2019 Dec;79(12):1273-1277
Authors: Emons G, Tempfer C, Battista MJ, Mustea A, Vordermark D, Uterus Commission of the AGO
Abstract
The role of adjuvant radiotherapy and/or chemotherapy in the primary treatment of endometrial cancer with a high risk of recurrence has still not been conclusively determined. The results of 3 large randomized controlled studies on different aspects of this issue have been published in full in recent months, and the relevant results are analyzed here.
PMID: 31875857 [PubMed]
Source: Geburtshilfe und Frauenheilkunde - Category: OBGYN Tags: Geburtshilfe Frauenheilkd Source Type: research
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Chemotherapy | Endometrial Cancer | OBGYN | Study